Analyst Upgrades

• Barclays upgraded Western Digital (WDC) to overweight from equal weight.
• LDK Solar (LDK) was upgraded to buy from hold at Needham.
• Legg Mason (LM) was upgraded to outperform from neutral at Macquarie.
• Agilent (A) was upgraded to buy from hold at Stifel Nicolaus.
• Wells Fargo upgraded Dean Foods (DF) to outperform from market perform and Developers Diversified (DDR) to market perform from underperform.
• Deutsche Bank also upgraded Developers Diversified, to buy from hold.
• Northrop Grumman (NOC) was upgraded to sell from conviction sell at Goldman.
• MYR Group (MYRG) was upgraded to buy from hold at BB&T.

Analyst Upgrades

• Wells Fargo upgraded Gap (GPS) to outperform from market perform, citing valuation and expectations for EPS to grow in FY11. The firm thinks consensus estimates are achievable and has a $20 to $22 target valuation range for shares.
• BMO Capital upgraded Abercrombie (ANF) to outperform from market perform and has a $43 target on the stock. The firm believes Abercrombie's domestic business is turning and that the company is beginning to take share from competitors.
• Piper Jaffray upgraded Codexis (CDXS) to overweight from neutral as it believes Shell's (RDS.A) biofuel commercialization plans and a potential carbon capture partnership present near-term catalysts for the stock. The firm upped its target for shares to $12 from $11.
• Tortoise Energy Capital (TYY) and Tortoise Energy (TYG) were upgraded to buy from hold at Wunderlich.
• Comerica (CMA) was upgraded to outperform from neutral at Baird.
• Methanex (MEOH) was upgraded to strong buy from outperform at Raymond James.

Analyst Upgrades

• Wells Fargo upgraded T. Rowe Price (TROW) to outperform from market perform, citing strong flows and a potential recovery in the U.S. equity markets.
• UBS upgraded BorgWarner (BWA) to buy from neutral and raised its price target to $50 from $48. The firm expects BorgWarner to benefit from fuel economy regulation.
• Cowen upgraded Celgene (CELG) to neutral from underperform, citing improved fundamentals and valuation for the upgrade.
• TRW Automotive (TRW) was upgraded to overweight from equal weight at Morgan Stanley.
• Finish Line (FINL) was upgraded to buy from hold at Citigroup.
• Jazz Pharmaceutical (JAZZ) was upgraded to overweight from equal weight at Barclays.